Sign In
Buy IEX
IDEX Earnings Calls
| Release date | Oct 29, 2025 |
| EPS estimate | $1.93 |
| EPS actual | $2.03 |
| EPS Surprise | 5.18% |
| Revenue estimate | 861.436M |
| Revenue actual | 878.7M |
| Revenue Surprise | 2.00% |
| Release date | Jul 30, 2025 |
| EPS estimate | $2.00 |
| EPS actual | $2.07 |
| EPS Surprise | 3.50% |
| Revenue estimate | 871.979M |
| Revenue actual | 865.4M |
| Revenue Surprise | -0.754% |
| Release date | May 01, 2025 |
| EPS estimate | $1.64 |
| EPS actual | $1.75 |
| EPS Surprise | 6.71% |
| Revenue estimate | 806.333M |
| Revenue actual | 814.3M |
| Revenue Surprise | 0.99% |
| Release date | Feb 04, 2025 |
| EPS estimate | $2.03 |
| EPS actual | $2.04 |
| EPS Surprise | 0.493% |
| Revenue estimate | 866.066M |
| Revenue actual | 862.9M |
| Revenue Surprise | -0.366% |
Last 4 Quarters for IDEX
Below you can see how IEX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 04, 2025 |
| Price on release | $218.65 |
| EPS estimate | $2.03 |
| EPS actual | $2.04 |
| EPS surprise | 0.493% |
| Date | Price |
|---|---|
| Jan 29, 2025 | $218.88 |
| Jan 30, 2025 | $224.11 |
| Jan 31, 2025 | $224.31 |
| Feb 03, 2025 | $218.86 |
| Feb 04, 2025 | $218.65 |
| Feb 05, 2025 | $197.58 |
| Feb 06, 2025 | $199.32 |
| Feb 07, 2025 | $195.94 |
| Feb 10, 2025 | $196.45 |
| 4 days before | -0.105% |
| 4 days after | -10.15% |
| On release day | -9.64% |
| Change in period | -10.25% |
| Release date | May 01, 2025 |
| Price on release | $175.25 |
| EPS estimate | $1.64 |
| EPS actual | $1.75 |
| EPS surprise | 6.71% |
| Date | Price |
|---|---|
| Apr 25, 2025 | $173.00 |
| Apr 28, 2025 | $174.10 |
| Apr 29, 2025 | $172.20 |
| Apr 30, 2025 | $173.97 |
| May 01, 2025 | $175.25 |
| May 02, 2025 | $181.45 |
| May 05, 2025 | $181.73 |
| May 06, 2025 | $179.54 |
| May 07, 2025 | $180.09 |
| 4 days before | 1.30% |
| 4 days after | 2.76% |
| On release day | 3.54% |
| Change in period | 4.10% |
| Release date | Jul 30, 2025 |
| Price on release | $164.28 |
| EPS estimate | $2.00 |
| EPS actual | $2.07 |
| EPS surprise | 3.50% |
| Date | Price |
|---|---|
| Jul 24, 2025 | $183.66 |
| Jul 25, 2025 | $185.69 |
| Jul 28, 2025 | $184.43 |
| Jul 29, 2025 | $185.18 |
| Jul 30, 2025 | $164.28 |
| Jul 31, 2025 | $163.51 |
| Aug 01, 2025 | $159.12 |
| Aug 04, 2025 | $158.25 |
| Aug 05, 2025 | $161.84 |
| 4 days before | -10.55% |
| 4 days after | -1.49% |
| On release day | -0.469% |
| Change in period | -11.88% |
| Release date | Oct 29, 2025 |
| Price on release | $173.40 |
| EPS estimate | $1.93 |
| EPS actual | $2.03 |
| EPS surprise | 5.18% |
| Date | Price |
|---|---|
| Oct 23, 2025 | $168.37 |
| Oct 24, 2025 | $167.95 |
| Oct 27, 2025 | $167.60 |
| Oct 28, 2025 | $166.95 |
| Oct 29, 2025 | $173.40 |
| Oct 30, 2025 | $170.30 |
| Oct 31, 2025 | $171.46 |
| Nov 03, 2025 | $168.25 |
| Nov 04, 2025 | $167.86 |
| 4 days before | 2.99% |
| 4 days after | -3.19% |
| On release day | -1.79% |
| Change in period | -0.303% |
IDEX Earnings Call Transcript Summary of Q3 2025
IDEX reported better-than-expected Q3 2025 results driven by strength in its Health & Science Technologies (HST) and select Fluid & Metering Technologies (FMT) businesses, with organic orders +7% and organic sales +5% year-over-year. HST showed particularly strong momentum (orders record $390M, revenue +10% organic) led by pharma, data centers, semiconductor MRO and space & defense; HST margins expanded materially. FMT benefited from the intelligent water platform and pricing execution; Fire & Safety Diversified Products (FSDP) faced volume weakness due to funding/disruption and equipment replenishment slowdowns. Company-wide adjusted EBITDA margin expanded ~40 bps in the quarter, platform optimization and cost containment delivered $17M in Q3 and are on track for >$60M annual savings. Free cash flow remained strong ($189M), with 123% FCF conversion and ~$1.1B liquidity; IDEX repurchased $75M of stock in the quarter (YTD $175M) and raised buyback authorization to $1B. Management narrowed full-year adjusted EPS guidance to $7.86–$7.91 while keeping FY organic growth at ~1% and adjusted EBITDA margin 26.5%–27.5%. Strategic focus shifts from large transformational M&A to integrating recently acquired growth platforms (apply the 8020 operating philosophy), pursuing selective bolt-ons, driving operational improvements, and returning excess cash to shareholders. Management expects continued macro uncertainty into 2026, but believes the company is positioned to drive sustainable, higher-quality organic growth as platform integrations take hold.
